Jim Cramer on Hinge Health: "I Just Say Buy That One and Put It Away"
Hinge Health, Inc. (NYSE:)
Oh, we like Hinge Health. We like Hinge Health. It’s just kind of when like Medline the other day, it’s just going to quietly go higher. It’s up three points today. That’s a very big move. But when I see a stock like Hinge Health, I just say, okay, look, it’s got a model for patient education to help the patients. They seem like level-headed people, and I just say buy that one and put it away. I think that was going to do well for a long time.
Hinge Health, Inc. (NYSE:HNGE) develops digital health software focused on musculoskeletal care, covering injury recovery, chronic pain management, and post-surgical rehabilitation. Cramer made some positive comments about the stock when a caller asked about it during the January 30 episode. He remarked:
… If you remember when they came on, I thought they were terrific, and they are part of the solution, not the problem. I think that that is going to be one of the better stocks we’ve seen in the healthcare sector.
While we acknowledge the potential of HNGE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Alibaba CEO confirms departure of Qwen AI division head
NZD/USD holds onto gains near 0.5950 as US Dollar’s rally hits pause
First Bullish MACD Cross Since 2020: 5 Altcoins Positioned for a Potential 50x Expansion Move
IMF’s Georgieva: Global economic resilience being tested yet again by new Middle East conflict
